This kind of powerful trio
$Clover Health (CLOV.US)$ Today, unsurprisingly, I'm almost bald and barefoot. The hour K was also very strong. This is a large institution opening a position. The institutions that came in in May after the financial report took profit (doubling or not?). It makes no sense for retail investors to pay their chips at this time.
To be honest, it's a dilemma. The advantage is that if the Clover model is widely accepted, it has a market value of tens of billions of dollars, let alone a few tens of billions of dollars. As long as you keep growing, manage expenses well, and fly. The downside is that it weighs too many cheap chips, and the other is that institutions are unwilling to buy chamath (see Sofi); the price will be extremely resistant after 6 or 7 yuan is added.
The prediction should be that next week you can get an analyst upgrade or recommended buy. At that time, there should be a big squat back, and pay attention to taking profits and buying back.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
QMengColdJoke OP : Still measure the cross, not in a hurry, but be careful.